Amazon and First Databank (FDB) have agreed to make FDB’s drug information available via simple queries via the Alexa voice agent.
Clinicians at FDB, which provides drug and medical device knowledge to healthcare professionals, will author clinical drug information specifically for Alexa based on their review of the most relevant content from the company’s proprietary consumer drug information database.
The project aims to provide custom content allowing consumers to ask about a drug’s effect such as drug interactions, side effects, precautions and the drug’s class.
“People lead busy lives and voice provides a simple way to get helpful information about medications including side effects and drug interactions, for themselves and the people they care for,” stated Bob Katter, president, FDB. “This information will complement advice from their medical and pharmacy teams.”